I. Name of engineering project: construct albumen chip and testing instrument manufacturing base　　
II. Construction unit of engineering project:  Nanjing Dayuan Biotech Corporation Ltd　　
III. Main content of engineering project
Nanjing Dayuan Biotech Engineering Corporation Ltd is exclusively invested by Singpore Dayuan Biology Company and is a high-tech enterprise in Nanjing, holding license to manufacture medical instruments and having registration license to manufacture PBT bio-chip recognition instrument. The laboratory has the fundamental eqipment which is necessary to carry out developing and manufacturing chip and has developed and reported 5 albumen testing chip, 1 of which has acquired new medicine certificate and the remaining would soon obtain certificate. The manufacturing base will have the capacity to manufacture 3 million sets of albumen chip and 50 million chip recognition instruments every year, and the marketing profit is supposed to reach 0.6 billion yuan, with 0.15 billion Yuan profit.
IV. Expectable overall investment of engineering project
1. Overall investment of engineering project: 80 million Yuan
2. Term of project construction: 2 years
3. Expectable rate of yield of engineering project: 40%
4. Expectable term of investment returns of engineering project: 3 years
V. Premilinary cooperation suggestion
Joint venture in fund and shares, development and marketing
VI. Linkman of engineering project: Wuxiong Chen
Correspondence address: 5, Tianpu Road, Pukou Economical Development Zone, Nanjing
Zip code: 211800
Telephone: 025-58289505
Fax: 025-58289575
Email: wilsoncwh@sohu.com